Disparities Details by Sex for 2012
IID-11.2 : Adolescents receiving 2+ doses of varicella vaccine by age 13–15 years (percent)
This chart compares rates by population.
Error Bar (I) represents the 95% confidence interval.
Additional footnotes may apply to these data. Please refer to footnotes below the data table for further information.
See also Disparities Overview by Sex for IID-11.2
IID-11.2 Increase the vaccination coverage level of 2 doses of varicella vaccine for adolescents by age 13 to 15 years (excluding children who have had varicella)
Adolescents receiving 2+ doses of varicella vaccine by age 13–15 years (percent)
1 Baseline has been revised. See Data Details for more information.
Data are subject to revision and may have changed since a previous release.
Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.
Data are not available or not collected for populations not shown.
CI: 95% confidence interval.
- The better group rate for this objective, 77.2%, was attained by the female population.
- The worse group rate for this objective, 76.4%, was attained by the male population.
- The absolute difference (or range) between the best and worst group rates was 0.8 percentage points.
- The best group rate was <1.100 times the worst group rate.
The female population achieved the better group rate for this objective, 77.2%.
The better group rate was <1.1 times the rate for the male population.